-
Molecular Therapy, 2010, Vol.18, No.11, pp.2006-2017
-
BMC Cancer, 2015, 15:603
-
addgene, 901 pLNCX myr HA Akt1, Plasmid#9005
-
addgene, Sequence Analyzer: 901, pLNCX myr HA Akt1 Seuencing Results
-
GASTROENTEROLOGY, 2013, 145, pp.456-465
-
Clin Cancer Res, 20170115, Vol.23, No.2, pp.478-488
-
PNAS, 2007, Vol.104, No.29, pp.12105-12110
-
Immunol Lett., 2008, 116 (2), pp.104-110
-
OncoImmunology, 2015, 4:5, e1005448
-
BMC Cancer, 2015, 15:603
-
BMC Cancer, 2015, 15:603
-
addgene, 901 pLNCX myr HA Akt1, Plasmid#9005
-
addgene, 901 pLNCX myr HA Akt1, Plasmid#9005
-
addgene, Sequence Analyzer: 901, pLNCX myr HA Akt1 Seuencing Results
-
addgene, Sequence Analyzer: 901, pLNCX myr HA Akt1 Seuencing Results
-
GASTROENTEROLOGY, 2013, 145, pp.456-465
-
GASTROENTEROLOGY, 2013, 145, pp.456-465
-
Clin Cancer Res, 20170115, Vol.23, No.2, pp.478-488
-
Clin Cancer Res, 20170115, Vol.23, No.2, pp.478-488
-
PNAS, 2007, Vol.104, No.29, pp.12105-12110
-
PNAS, 2007, Vol.104, No.29, pp.12105-12110
-
Immunol Lett., 2008, 116 (2), pp.104-110
-
Immunol Lett., 2008, 116 (2), pp.104-110
-
OncoImmunology, 2015, 4:5, e1005448
-
OncoImmunology, 2015, 4:5, e1005448
-
Molecular Therapy, 2010, Vol.18, No.11, pp.2006-2017
-
Molecular Therapy, 2010, Vol.18, No.11, pp.2006-2017
-
Molecular Therapy, 2010, Vol.18, No.11, pp.2006-2017
-
BMC Cancer, 2015, 15:603
-
addgene, 901 pLNCX myr HA Akt1, Plasmid#9005
-
addgene, Sequence Analyzer: 901, pLNCX myr HA Akt1 Seuencing Results
-
GASTROENTEROLOGY, 2013, 145, pp.456-465
-
Clin Cancer Res, 20170115, Vol.23, No.2, pp.478-488
-
PNAS, 2007, Vol.104, No.29, pp.12105-12110
-
Immunol Lett., 2008, 116 (2), pp.104-110
-
OncoImmunology, 2015, 4:5, e1005448